Cross Cancer Institute unveils promising cancer treatment
Source ↗
👁 0
💬 0
Eight years ago, Ron Ohlmann’s prospects quickly went from a health issue caught early and, “You’ve got years to worry about it,” to troubling prostate-specific antigen (PSA) spikes — and an aggressive form of cancer. Read More
Comments (0)